Inventor · disambiguated record
Sibylle Dames
Also filed as: DAMES SIBYLLE
5 granted patents·10 pending applications·27 citations·filing 2018–2024
76Inventor score
Files withSILENCE THERAPEUTICS GMBH11UNIV BERN3ASOCIACION CENTRO DE INVESTIG COOPERATIVA EN BIOCIENCIAS CIC BIOGUNE1
Top patents by PatentIndex Score
15 records- 0192US11499153B2Nucleic acids for inhibiting expression of LPA in a cellSILENCE THERAPEUTICS GMBH·Filed 2021·Granted Nov 15, 2022·2 cites·28 claims
- 0292US11319537B2Nucleic acids for inhibiting expression of LPA in a cellSILENCE THERAPEUTICS GMBH·Filed 2018·Granted May 3, 2022·18 cites·15 claims
- 0390US11174483B2Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2018·Granted Nov 16, 2021·6 cites·19 claims
- 0488US12054717B2Nucleic acids for inhibiting expression of LPA in a cellSILENCE THERAPEUTICS GMBH·Filed 2022·Granted Aug 6, 2024·1 cites·17 claims
- 0580US2024327843A1Nucleic acids for inhibiting expression of lpa in a cellSILENCE THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 0663US11820971B2Nucleic acids for inhibiting expression of PROS1 in a cellUNIV BERN·Filed 2022·Granted Nov 21, 2023·0 cites·19 claims
- 0763US2022002722A1Nucleic acids for inhibiting expression of lpa in a cellSILENCE THERAPEUTICS GMBH·Filed 2019·Application pending·0 cites
- 0862US2022025377A1Products and compositionsSILENCE THERAPEUTICS GMBH·Filed 2021·Application pending·0 cites
- 0955US2025136977A1Nucleic acids for inhibiting expression of complement factor b (cfb) in a cellSILENCE THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 1055US2022135974A1Nucleic acids for inhibiting expression of pros1 in a cellUNIV BERN·Filed 2021·Application pending·0 cites
- 1154US2024240187A1Sirna targeting tmprss6 for the treatment of myeloproliferative disordersSILENCE THERAPEUTICS GMBH·Filed 2022·Application pending·0 cites
- 1253US2025230441A1Nucleic acids for inhibiting expression of MASP-2 in a cellSILENCE THERAPEUTICS GMBH·Filed 2023·Application pending·0 cites
- 1347US2022017899A1Nucleic acids for inhibiting expression of c3 in a cellSILENCE THERAPEUTICS GMBH·Filed 2019·Application pending·0 cites
- 1444US2022243202A1Nucleic acids for inhibiting expression of pros1 in a cellUNIV BERN·Filed 2020·Application pending·0 cites
- 1544US2024229041A2Nucleic acids for inhibiting expression of cnnm4 in a cellASOCIACION CENTRO DE INVESTIG COOPERATIVA EN BIOCIENCIAS CIC BIOGUNE·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sibylle Dames files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →